LiftmyCVLiftmyCV
RI

Head, Radiopharmaceutical Diagnostic Development

RayzeBio, IncRemoteRemote, US$221,749–$268,707 per year
AI job summary

RayzeBio, a subsidiary of Bristol Myers Squibb, seeks a Head of Radiopharmaceutical Diagnostic Development to lead the diagnostic and companion imaging portfolio. The role encompasses building global development plans, regulatory strategy, and lifecycle management for diagnostic products. Ideal candidates will have extensive experience in radiopharmaceuticals, with the ability to navigate regulatory requirements across multiple regions. This position also includes leading a high-performing team and collaborating closely with various departments to ensure timely and compliant delivery of diagnostic agents.

Job description

Position Summary

The Head, Radiopharmaceutical Diagnostic Development will provide strategic and operational leadership for RayzeBio's diagnostic and companion imaging radiopharmaceutical portfolio, including PET and SPECT imaging agents used for patient selection, dosimetry, and disease monitoring across RayzeBio's radioligand therapy (RLT) programs (e.g., RYZ101, RYZ701, and the broader RYZ-series pipeline). This role owns the diagnostic development strategy end to end — from candidate nomination and CMC development through tech transfer, clinical supply, regulatory submission, and health authority approval — and partners closely with CMC, Quality, Regulatory Affairs, Clinical Development, Manufacturing, Isotope Supply Chain, and Commercial to ensure diagnostic agents are delivered on time, in compliance, and aligned to the needs of each therapeutic program. The role is global in scope: it is accountable for building and executing global development plans across the United States, Canada, the European Union, Australia/New Zealand, and the Asia-Pacific region, and for the ongoing lifecycle management of approved diagnostic products across all markets in which RayzeBio operates.

Job Responsibilities

  • Define and own the diagnostic and companion imaging development strategy across RayzeBio's portfolio, aligning imaging agent timelines with the therapeutic programs they support.
  • Build and execute global development plans for diagnostic radiopharmaceuticals, coordinating regulatory strategy, filings, and market entry across the United States, Canada, the European Union, Australia/New Zealand, and the Asia-Pacific region.
  • Own lifecycle management for approved diagnostic products, including post-approval changes, label updates, supplemental filings, manufacturing changes, and continued market compliance across all regions in which the products are marketed.
  • Tailor regional regulatory and CMC strategies to align with local health authority requirements (e.g., FDA, Health Canada, EMA, TGA, and APAC regulatory bodies) while maintaining a unified global development plan.
  • Lead CMC strategy, process development, and validation for diagnostic radiopharmaceuticals, including radiosynthesis, radiolabeling, and quality control methods for isotopes such as Ga-68, F-18, and Cu-64.
  • Direct technology transfer and scale-up of diagnostic manufacturing processes across internal sites and third-party CDMOs/CROs, ensuring robust, reproducible, and inspection-ready operations.
  • Serve as the primary strategic point of contact with FDA and other health authorities for diagnostic imaging agent submissions, meetings, and inspections, including IND, NDA, and ANDA filings.
  • Author and oversee CMC sections, briefing documents, and regulatory correspondence for diagnostic development programs; lead health authority interactions in partnership with Regulatory Affairs.
  • Partner with Clinical Development and Translational Medicine to design imaging strategies that support patient selection, dosimetry, and biomarker objectives for RLT clinical trials.
  • Build, mentor, and lead a high-performing team of scientists and CMC/regulatory professionals supporting diagnostic development.
  • Ensure diagnostic development activities comply with 21 CFR Parts 211 and 212, USP, NRC requirements, and other applicable radiopharmaceutical regulations.
  • Manage external supplier, CDMO, and CRO relationships supporting diagnostic manufacturing, analytical testing, and clinical supply.
  • Represent RayzeBio externally with industry and standards bodies (e.g., SNMMI, MITA, USP) to help shape evolving standards for diagnostic radiopharmaceuticals.
  • Own budget, resourcing, and risk mitigation planning for the diagnostic development function; report progress and risks to senior leadership.
  • Identify opportunities to apply digital tools and AI to improve development speed, data integrity, and decision-making across diagnostic programs.
  • Willing to travel approximately 20–30% of the time; occasional evening or weekend work may be required to support inspections or health authority interactions.

Education and Experience

  • PharmD, PhD, or other advanced scientific degree, with 10+ years of experience in radiopharmaceutical, PET/SPECT diagnostic, or nuclear medicine product development, or an equivalent combination of education and experience.
  • Demonstrated success leading CMC and regulatory strategy for diagnostic or companion imaging radiopharmaceuticals through IND-enabling activities and NDA/ANDA approval.
  • Hands-on experience with cGMP radiopharmaceutical manufacturing, including cyclotron- or generator-produced isotopes and automated radiosynthesis platforms.
  • Track record of leading successful FDA inspections (including pre-approval inspections) and direct health authority interactions.
  • Prior people-leadership experience managing cross-functional scientific, regulatory, and/or quality teams.
  • Experience building and executing global development and regulatory plans across multiple regions (e.g., US, Canada, EU, Australia/New Zealand, APAC), including lifecycle management of approved products.
  • Deep subject-matter expertise in PET/SPECT diagnostic radiopharmaceutical development, manufacturing, and regulatory pathways.
  • Strong understanding of companion diagnostic strategy and how imaging agents support patient selection for radioligand therapy programs.
  • Proven ability to lead through influence in a matrix organization, building alignment across functions and with senior leadership.
  • Strong scientific and regulatory judgment, with the ability to translate complex CMC and clinical data into clear, decision-oriented recommendations.
  • Executive-level written and verbal communication skills, including experience representing programs to FDA, investigators, and industry bodies.
  • Ability to operate effectively in a highly regulated environment and adhere to RayzeBio's guidelines and standard operating procedures (SOPs).
  • Patient-focused, with a genuine commitment to improving outcomes for people with cancer through innovative radiopharmaceuticals.
  • Working knowledge of international regulatory frameworks and health authority expectations across North America, Europe, Australia/New Zealand, and the Asia-Pacific region, and experience managing product lifecycle activities on a global scale.

Compensation Overview

Remote - United States - US: $221,749 - $268,707. The starting compensation range(s) for this role are listed above for a full-time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate takes into account characteristics of the job, such as required skills, where the job is performed, the employee’s work schedule, job-related knowledge, and experience. Final, individual compensation will be decided based on demonstrated experience.

Job details

Published
August 12, 2026
Job source
myworkdayjobs
Workplace
Remote · Remote, US
First seen
August 13, 2026
AI match explained

See how well you match this job

Log in or sign up and Eva will compare your profile with this role, explain your strengths and show what to improve.

Sign up to see your matchAlready have an account? Log in

More at RayzeBio, Inc

Similar jobs from this company

None listed.

Across the market

Similar jobs from other companies

Third-party content disclaimer

Full job descriptions are sourced directly from third-party applicant tracking systems (ATS), job boards, recruitment platforms, and employer career pages.

LiftmyCV does not claim ownership of this content or guarantee its accuracy or current availability. All original content is the intellectual property of the respective employers or other rights holders.

LiftmyCV hiring intelligence, availability checks, and related-job recommendations are generated from LiftmyCV data and public sources.

If you prefer, you may apply directly via the original listing for transparency.